{"id":61039,"date":"2024-02-28T07:21:56","date_gmt":"2024-02-28T07:21:56","guid":{"rendered":"https:\/\/medsname.com\/ursodec\/"},"modified":"2026-04-30T10:23:39","modified_gmt":"2026-04-30T10:23:39","slug":"ursodec","status":"publish","type":"product","link":"https:\/\/medsbase.com\/cs\/product\/ursodec\/","title":{"rendered":"Ursodec"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:14px 18px;margin:0 0 18px 0;border-radius:4px;\">\n<h3 style=\"margin:0 0 8px 0;font-size:1.05em;\">Rychl\u00e1 odpov\u011b\u010f<\/h3>\n<p><strong>Ursodec<\/strong> obsahuje <strong>kyselina ursodeoxycholov\u00e1 (UDCA) 150 mg<\/strong> na tabletu \u2014 prvn\u00ed volba peror\u00e1ln\u00ed terapie pro prim\u00e1rn\u00ed bili\u00e1rn\u00ed cholangitidu (PBC) a hlavn\u00ed peror\u00e1ln\u00ed mo\u017enost pro rozpou\u0161t\u011bn\u00ed cholesterolov\u00fdch \u017elu\u010dov\u00fdch kamen\u016f. Typick\u00e1 d\u00e1vka pro dosp\u011bl\u00e9 je 13\u201315 mg\/kg\/den v rozd\u011blen\u00fdch d\u00e1vk\u00e1ch s j\u00eddlem pro PBC, 8\u201310 mg\/kg\/den pro rozpou\u0161t\u011bn\u00ed \u017elu\u010dov\u00fdch kamen\u016f. Tablety s vy\u0161\u0161\u00ed d\u00e1vkou (Udiliv 300mg) sni\u017euj\u00ed po\u010det tablet.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f6f8;border:1px solid #e1e4e8;border-radius:4px;padding:14px 18px;margin:18px 0;display:flex;flex-wrap:wrap;gap:14px;font-size:0.95em;\"><span>\u2705 <strong>WHO-GMP certifikov\u00e1no<\/strong> v\u00fdrobce<\/span><span>\ud83d\udce6 <strong>Diskr\u00e9tn\u00ed balen\u00ed<\/strong><\/span><span>\ud83c\udf0d <strong>Dod\u00e1n\u00ed po cel\u00e9m sv\u011bt\u011b<\/strong><\/span><span>\ud83d\udcac <a href=\"\/cs\/reviews\/\">1,400+ recenz\u00ed z\u00e1kazn\u00edk\u016f<\/a><\/span><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Ka\u017ed\u00e1 objedn\u00e1vka je pokryta na\u0161\u00ed <a href=\"https:\/\/medsbase.com\/cs\/medsbase-re-shipment-assurance-policy\/\"><strong>Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/strong><\/a> \u2014 pokud va\u0161e z\u00e1silka nedoraz\u00ed do 20 pracovn\u00edch dn\u016f, p\u0159epos\u00edl\u00e1me ji.<\/p>\n<h2>Co je kyselina ursodeoxycholov\u00e1<\/h2>\n<p>Kyselina ursodeoxycholov\u00e1 (UDCA, tak\u00e9 naz\u00fdvan\u00e1 ursodiol) je p\u0159irozen\u011b se vyskytuj\u00edc\u00ed sekund\u00e1rn\u00ed \u017elu\u010dov\u00e1 kyselina. Terapeuticky sou\u010dasn\u011b p\u016fsob\u00ed t\u0159emi zp\u016fsoby: <strong>vyt\u011bs\u0148uje cytotoxick\u00e9 hydrofobn\u00ed \u017elu\u010dov\u00e9 kyseliny<\/strong> (chenodeoxycholovou, deoxycholovou, lithocholovou) z poolu \u017elu\u010dov\u00fdch kyselin, <strong>sni\u017euje sekreci cholesterolu do \u017elu\u010di<\/strong> (co\u017e rozpou\u0161t\u00ed cholesterolov\u00e9 \u017elu\u010dov\u00e9 kameny b\u011bhem m\u011bs\u00edc\u016f), a <strong>chr\u00e1n\u00ed cholangiocyty<\/strong> p\u0159ed po\u0161kozen\u00edm mediovan\u00fdm \u017elu\u010dov\u00fdmi kyselinami prost\u0159ednictv\u00edm cytoprotektivn\u00edch a imunomodula\u010dn\u00edch \u00fa\u010dink\u016f. Je to jedin\u00e1 peror\u00e1ln\u00ed terapie s prok\u00e1zan\u00fdm p\u0159\u00ednosem pro mortalitu a transplant-free survival u prim\u00e1rn\u00ed bili\u00e1rn\u00ed cholangitidy (Poupon 1991, 1994; metaanal\u00fdzy 2002, 2014).<\/p>\n<h2>Indikace<\/h2>\n<ul>\n<li><strong>Prim\u00e1rn\u00ed bili\u00e1rn\u00ed cholangitida (PBC)<\/strong> \u2014 terapie prvn\u00ed volby; 13\u201315 mg\/kg\/den v rozd\u011blen\u00fdch d\u00e1vk\u00e1ch s j\u00eddlem. ~60\u201370% biochemick\u00e1 odpov\u011b\u010f (normalizace alkalick\u00e9 fosfat\u00e1zy nebo v\u00fdrazn\u00fd pokles) b\u011bhem 12 m\u011bs\u00edc\u016f. U nerespond\u00e9r\u016f se p\u0159ech\u00e1z\u00ed na obeticholovou kyselinu nebo fibr\u00e1ty.<\/li>\n<li><strong>Rozpu\u0161t\u011bn\u00ed cholesterolov\u00fdch \u017elu\u010dov\u00fdch kamen\u016f<\/strong> \u2014 pro radiolucentn\u00ed kameny &lt; 15 mm ve funk\u010dn\u00edm \u017elu\u010dn\u00edku u pacient\u016f, kte\u0159\u00ed nemohou nebo necht\u011bj\u00ed podstoupit cholecystektomii. 8\u201310 mg\/kg\/den po dobu 6\u201324 m\u011bs\u00edc\u016f. Recidiva kamen\u016f po ukon\u010den\u00ed l\u00e9\u010dby je v\u00fdznamn\u00e1 (\u2248 50% za 5 let).<\/li>\n<li><strong>Prim\u00e1rn\u00ed sklerozuj\u00edc\u00ed cholangitida (PSC)<\/strong> \u2014 zlep\u0161uje biochemick\u00e9 parametry; p\u0159\u00ednos pro mortalitu nebyl prok\u00e1z\u00e1n. Vysok\u00e9 d\u00e1vky (28\u201330 mg\/kg\/den) jsou spojeny s hor\u0161\u00edmi v\u00fdsledky a jsou kontraindikov\u00e1ny.<\/li>\n<li><strong>Intrahepat\u00e1ln\u00ed cholest\u00e1za t\u011bhotn\u00fdch (ICP)<\/strong> \u2014 10\u201315 mg\/kg\/den (nebo 500 mg dvakr\u00e1t denn\u011b); sni\u017euje mate\u0159sk\u00fd pruritus a hladiny \u017elu\u010dov\u00fdch kyselin; m\u016f\u017ee sn\u00ed\u017eit fet\u00e1ln\u00ed komplikace.<\/li>\n<li><strong>Nealkoholick\u00e9 ztukovat\u011bn\u00ed jater (NAFLD)<\/strong> \u2014 biochemick\u00e9 parametry se zlep\u0161uj\u00ed, ale kvalitn\u00ed histologick\u00fd p\u0159\u00ednos nebyl prok\u00e1z\u00e1n; v sou\u010dasn\u00fdch doporu\u010den\u00edch se nejedn\u00e1 o terapii prvn\u00ed volby u NAFLD.<\/li>\n<li><strong>Jatern\u00ed posti\u017een\u00ed asociovan\u00e9 s cystickou fibr\u00f3zou<\/strong> \u2014 pou\u017e\u00edv\u00e1 se u d\u011bt\u00ed a dosp\u011bl\u00fdch s cholest\u00e1zou p\u0159i CF.<\/li>\n<\/ul>\n<h2>D\u00e1vkov\u00e1n\u00ed<\/h2>\n<table>\n<thead>\n<tr>\n<th>Indikace<\/th>\n<th>D\u00e1vka (mg\/kg\/den)<\/th>\n<th>D\u00e1vkovac\u00ed sch\u00e9ma<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>PBC<\/td>\n<td>13\u201315<\/td>\n<td>2\u20133 d\u00edl\u010d\u00ed d\u00e1vky s j\u00eddly<\/td>\n<\/tr>\n<tr>\n<td>Rozpu\u0161t\u011bn\u00ed cholesterolov\u00fdch \u017elu\u010dov\u00fdch kamen\u016f<\/td>\n<td>8\u201310<\/td>\n<td>2 d\u00edl\u010d\u00ed d\u00e1vky (s nejv\u011bt\u0161\u00ed d\u00e1vkou p\u0159ed span\u00edm)<\/td>\n<\/tr>\n<tr>\n<td>PSC<\/td>\n<td>13\u201315 (NEP\u0158EKRA\u010cUJTE 28 mg\/kg)<\/td>\n<td>2\u20133 d\u00edl\u010d\u00ed d\u00e1vky<\/td>\n<\/tr>\n<tr>\n<td>ICP (t\u011bhotenstv\u00ed)<\/td>\n<td>10\u201315<\/td>\n<td>2 rozd\u011blen\u00e9 d\u00e1vky<\/td>\n<\/tr>\n<tr>\n<td>Dopln\u011bk l\u00e9\u010dby NAFLD<\/td>\n<td>13\u201315<\/td>\n<td>2\u20133 d\u00edl\u010d\u00ed d\u00e1vky<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 18px;margin:18px 0;border-radius:4px;\">\n<h3 style=\"margin:0 0 8px 0;font-size:1.05em;\">Vyvarovat se pou\u017eit\u00ed na<\/h3>\n<ul>\n<li>Akutn\u00ed cholecystitida, cholangitida nebo obstrukce \u017elu\u010dov\u00fdch cest<\/li>\n<li>Zkamen\u011bl\u00e9 nebo pigmentov\u00e9 \u017elu\u010dov\u00e9 kameny (\u017e\u00e1dn\u00fd \u00fa\u010dinek na rozpou\u0161t\u011bn\u00ed)<\/li>\n<li>Neaktivn\u00ed \u017elu\u010dn\u00edk p\u0159i peror\u00e1ln\u00ed cholecystografii<\/li>\n<li>T\u011b\u017ek\u00e1 jatern\u00ed dekompenzace (Child-Pugh C) \u2014 konzultovat s hepatologem<\/li>\n<\/ul>\n<\/div>\n<h2>Vedlej\u0161\u00ed \u00fa\u010dinky<\/h2>\n<p>Obecn\u011b velmi dob\u0159e sn\u00e1\u0161en. Nej\u010dast\u011bj\u0161\u00ed: m\u00edrn\u00fd pr\u016fjem (5\u201310%), b\u0159i\u0161n\u00ed diskomfort, nevolnost, m\u00edrn\u00e1 vyr\u00e1\u017eka. Sv\u011bd\u011bn\u00ed se m\u016f\u017ee u PBC p\u0159echodn\u011b zhor\u0161it v prvn\u00edch t\u00fddnech p\u0159ed zlep\u0161en\u00edm. Vz\u00e1cn\u011b: kalcifikace \u017elu\u010dov\u00fdch kamen\u016f (posun k rentgenkontrastnosti) p\u0159i dlouhodob\u00e9m u\u017e\u00edv\u00e1n\u00ed.<\/p>\n<h2>Interakce l\u00e9k\u016f<\/h2>\n<ul>\n<li><strong>Sekvestranty \u017elu\u010dov\u00fdch kyselin (cholestyramin, colesevelam, colestipol)<\/strong> \u2014 v\u00e1\u017eou UDCA ve st\u0159ev\u011b a sni\u017euj\u00ed jej\u00ed vst\u0159eb\u00e1v\u00e1n\u00ed. Odd\u011blit pod\u00e1n\u00ed o \u2265 4\u20135 hodin.<\/li>\n<li><strong>Antacida obsahuj\u00edc\u00ed hlin\u00edk<\/strong> \u2014 v\u00e1\u017eou UDCA. Odd\u011blit pod\u00e1n\u00ed o \u2265 2 hodiny.<\/li>\n<li><strong>Estrogeny, or\u00e1ln\u00ed antikoncepce, klofibr\u00e1t<\/strong> \u2014 zvy\u0161uj\u00ed saturaci \u017elu\u010di cholesterolem a antagonizuj\u00ed \u00fa\u010dinek rozpou\u0161t\u011bn\u00ed \u017elu\u010dov\u00fdch kamen\u016f.<\/li>\n<li><strong>Ciprofloxacin, dapson<\/strong> \u2014 m\u00edrn\u011b zm\u011bn\u011bn\u00e1 absorpce; klinicky nev\u00fdznamn\u00e1.<\/li>\n<\/ul>\n<h2>T\u011bhotenstv\u00ed a kojen\u00ed<\/h2>\n<p>Rutinn\u011b se pou\u017e\u00edv\u00e1 off-label p\u0159i intrahepat\u00e1ln\u00ed cholest\u00e1ze t\u011bhotn\u00fdch s rozs\u00e1hl\u00fdmi bezpe\u010dnostn\u00edmi \u00fadaji. Kompatibiln\u00ed s kojen\u00edm (vylu\u010dov\u00e1n ve stopov\u00fdch mno\u017estv\u00edch do ml\u00e9ka; nebyly hl\u00e1\u0161eny \u017e\u00e1dn\u00e9 ne\u017e\u00e1douc\u00ed \u00fa\u010dinky u kojenc\u016f).<\/p>\n<h2>Skladov\u00e1n\u00ed<\/h2>\n<p>Skladujte p\u0159i teplot\u011b do 25 \u00b0C na such\u00e9m m\u00edst\u011b, v p\u016fvodn\u00edm obalu. Tablety jsou stabiln\u00ed po celou dobu trvanlivosti uvedenou na obalu, pokud jsou uchov\u00e1v\u00e1ny v suchu.<\/p>\n<h3>Pro\u010d objedn\u00e1vat z MedsBase<\/h3>\n<p>Ursodec je dod\u00e1v\u00e1n v\u00fdrobcem certifikovan\u00fdm WHO-GMP s kompletn\u00ed dokumentac\u00ed COA. Dod\u00e1v\u00e1me po cel\u00e9m sv\u011bt\u011b v nen\u00e1padn\u00e9m obalu a ka\u017ed\u00e1 objedn\u00e1vka je pokryta na\u0161\u00ed <a href=\"\/cs\/medsbase-re-shipment-assurance-policy\/\">Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/a>. P\u0159i platb\u011b kartou se ve v\u00fdpisu objev\u00ed regulovan\u00fd platebn\u00ed procesor (regulovan\u00fd procesor plateb kartou), nikdy \"MedsBase\" nebo n\u00e1zev l\u00e9ku.<\/p>\n<h2 id=\"faqs\">\u010casto kladen\u00e9 dotazy<\/h2>\n<h3>Za jak dlouho uvid\u00edm v\u00fdsledky u prim\u00e1rn\u00ed bili\u00e1rn\u00ed cholangitidy?<\/h3>\n<p>Alkalick\u00e1 fosfat\u00e1za obvykle kles\u00e1 b\u011bhem 4\u20138 t\u00fddn\u016f a trend po 12 m\u011bs\u00edc\u00edch p\u0159edpov\u00edd\u00e1 dlouhodob\u00fd v\u00fdsledek. Torontsk\u00e1, Pa\u0159\u00ed\u017esk\u00e1-1 a Pa\u0159\u00ed\u017esk\u00e1-2 krit\u00e9ria definuj\u00ed \u201cbiochemick\u00e9ho respondera\u201d po 1 roce podle prahov\u00fdch hodnot ALP, AST a bilirubinu. Nereaguj\u00edc\u00ed pacienti by m\u011bli s hepatologem probrat p\u0159id\u00e1n\u00ed obeticholov\u00e9 kyseliny nebo fibr\u00e1tu.<\/p>\n<h3>M\u016f\u017ee UDCA rozpustit jak\u00fdkoli druh \u017elu\u010dov\u00e9ho kamene?<\/h3>\n<p>Pouze cholesterolov\u00e9 kameny, pouze pokud jsou radiolucentn\u00ed na zobrazovac\u00edch vy\u0161et\u0159en\u00edch, pouze ve funguj\u00edc\u00edm \u017elu\u010dn\u00edku a pouze pokud jsou &lt; 15 mm. Kalcifikovan\u00e9, pigmentov\u00e9 nebo \u010d\u00e1ste\u010dn\u011b kalcifikovan\u00e9 kameny nereaguj\u00ed.<\/p>\n<h3>Pro\u010d m\u011b m\u016fj l\u00e9ka\u0159 chce m\u00edt na UDCA nav\u017edy kv\u016fli PBC?<\/h3>\n<p>PBC je chronick\u00e1 autoimunitn\u00ed cholangitida. UDCA m\u011bn\u00ed pr\u016fb\u011bh onemocn\u011bn\u00ed, ale nel\u00e9\u010d\u00ed ho. Po vysazen\u00ed UDCA doch\u00e1z\u00ed b\u011bhem t\u00fddn\u016f k biochemick\u00e9mu relapsu. Do\u017eivotn\u00ed terapie v d\u00e1vce 13\u201315 mg\/kg\/den je standardem.<\/p>\n<h3>M\u016f\u017eu ho u\u017e\u00edvat b\u011bhem t\u011bhotenstv\u00ed?<\/h3>\n<p>Ano \u2014 UDCA je standardn\u00ed l\u00e9\u010dba intrahepat\u00e1ln\u00ed cholest\u00e1zy t\u011bhotn\u00fdch. Desetilet\u00ed pou\u017e\u00edv\u00e1n\u00ed neprok\u00e1zala \u017e\u00e1dn\u00e9 po\u0161kozen\u00ed plodu a sni\u017euje mate\u0159sk\u00fd pruritus a hladiny \u017elu\u010dov\u00fdch kyselin.<\/p>\n<h3>Zp\u016fsob\u00ed UDCA \u00fabytek nebo n\u00e1r\u016fst hmotnosti?<\/h3>\n<p>Ani jedno, u v\u011bt\u0161iny pacient\u016f. M\u00edrn\u00fd pr\u016fjem m\u016f\u017ee u mal\u00e9 \u010d\u00e1sti pacient\u016f zp\u016fsobit nepatrn\u00fd \u00fabytek hmotnosti na za\u010d\u00e1tku.<\/p>\n<h3>Funguje UDCA u nealkoholick\u00e9 tukov\u00e9 choroby jater?<\/h3>\n<p>Zlep\u0161uje biochemick\u00e9 parametry (ALT, AST). Zda zlep\u0161uje jatern\u00ed histologii a v\u00fdsledky, nebylo prok\u00e1z\u00e1no ve velk\u00fdch studi\u00edch. Sou\u010dasn\u00e9 pokyny pro NAFLD\/NASH nedoporu\u010duj\u00ed UDCA jako rutinn\u00ed terapii.<\/p>\n<h3>Mohu p\u00edt alkohol p\u0159i u\u017e\u00edv\u00e1n\u00ed UDCA?<\/h3>\n<p>V\u011bt\u0161ina pacient\u016f u\u017e\u00edvaj\u00edc\u00edch UDCA m\u00e1 z\u00e1kladn\u00ed jatern\u00ed onemocn\u011bn\u00ed. Alkohol je nejlep\u0161\u00ed zcela vynechat u PBC, PSC a v\u00fdznamn\u00fdch jatern\u00edch onemocn\u011bn\u00ed.<\/p>\n<h3>Jak\u00fd je rozd\u00edl mezi UDCA a \u017elu\u010dov\u00fdmi solemi v dopl\u0148c\u00edch stravy?<\/h3>\n<p>UDCA je specifick\u00e1 \u017elu\u010dov\u00e1 kyselina (kyselina ursodeoxycholov\u00e1). Obecn\u00e9 dopl\u0148ky stravy s \u201c\u017elu\u010dov\u00fdmi solemi\u201d jsou sm\u011bsi p\u0159\u00edrodn\u00edch \u017elu\u010dov\u00fdch kyselin bez standardizace terapeutick\u00e9 d\u00e1vky. Klinicky se pro PBC a rozpou\u0161t\u011bn\u00ed \u017elu\u010dov\u00fdch kamen\u016f pou\u017e\u00edvaj\u00ed pouze tablety s \u010di\u0161t\u011bnou UDCA.<\/p>\n<h3>Jak se monitoruje UDCA?<\/h3>\n<p>Pro PBC: ALP, ALT, AST, GGT, celkov\u00fd bilirubin ka\u017ed\u00e9 3 m\u011bs\u00edce v prvn\u00edm roce, pot\u00e9 ka\u017ed\u00fdch 6 m\u011bs\u00edc\u016f. Pro rozpou\u0161t\u011bn\u00ed \u017elu\u010dov\u00fdch kamen\u016f: ultrazvuk po 6, 12 a 24 m\u011bs\u00edc\u00edch ke sledov\u00e1n\u00ed velikosti kamen\u016f.<\/p>\n<h3>M\u016f\u017ee b\u00fdt vysok\u00e1 d\u00e1vka UDCA \u0161kodliv\u00e1?<\/h3>\n<p>U prim\u00e1rn\u00ed sklerozuj\u00edc\u00ed cholangitidy byly d\u00e1vky \u2265 28 mg\/kg\/den spojeny s HOR\u0160\u00cdMI klinick\u00fdmi v\u00fdsledky (Lindor 2009 NEJM). Dr\u017ete se 13\u201315 mg\/kg\/den u PSC a nikdy nezvy\u0161ujte d\u00e1vku bez konzultace s odborn\u00edkem.<\/p>\n<h2>Dal\u0161\u00ed produkty pro j\u00e1tra a hepatologii<\/h2>\n<ul>\n<li><a href=\"\/cs\/udiliv\/\">Udiliv (UDCA 300 mg) \u2014 vy\u0161\u0161\u00ed s\u00edla UDCA, m\u00e9n\u011b tablet<\/a><\/li>\n<li><a href=\"\/cs\/hepatitis-medication\/\">V\u0161echna l\u00e9\u010diva na hepatitidu a j\u00e1tra<\/a><\/li>\n<li><a href=\"\/cs\/hepcinat\/\">Hepcinat (sofosbuvir) \u2014 p\u0159\u00edm\u00e9 antivirotikum pro chronickou HCV<\/a><\/li>\n<li><a href=\"\/cs\/myhep-all\/\">MyHep All (sofosbuvir + velpatasvir) \u2014 pan-genotypick\u00e9 HCV<\/a><\/li>\n<li><a href=\"\/cs\/celin\/\">Celin (vitamin C) \u2014 antioxida\u010dn\u00ed dopln\u011bk<\/a><\/li>\n<li><a href=\"\/cs\/l-glutathione-250mg\/\">L-Glutathion 250 mg \u2014 antioxidant pro jatern\u00ed redoxn\u00ed podporu<\/a><\/li>\n<\/ul>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 18px;margin:24px 0 0 0;border-radius:4px;\">\n<h3 style=\"margin:0 0 8px 0;font-size:1.05em;\">L\u00e9ka\u0159sk\u00e9 upozorn\u011bn\u00ed<\/h3>\n<p style=\"margin:0;\">Tyto informace jsou poskytov\u00e1ny pouze pro vzd\u011bl\u00e1vac\u00ed \u00fa\u010dely a nenahrazuj\u00ed l\u00e9ka\u0159skou pomoc. P\u0159ed zah\u00e1jen\u00edm, zm\u011bnou nebo ukon\u010den\u00edm jak\u00e9hokoli l\u00e9ku se v\u017edy pora\u010fte s kvalifikovan\u00fdm zdravotnick\u00fdm pracovn\u00edkem.<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>\u2705 Rozpou\u0161t\u00ed \u017elu\u010dov\u00e9 kameny<br \/>\n\u2705 Chr\u00e1n\u00ed jatern\u00ed bu\u0148ky<br \/>\n\u2705 Sni\u017euje toxicitu \u017elu\u010di<br \/>\n\u2705 Zlep\u0161uje funkci jater<br \/>\n\u2705 Zm\u00edr\u0148uje z\u00e1n\u011bt jater<\/p>\n<p>Ursodec obsahuje kyselinu ursodeoxycholovou.<\/p>","protected":false},"featured_media":61040,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3334],"product_tag":[4967,4728],"class_list":{"0":"post-61039","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-hepatitis-medication","9":"product_tag-ursodec","10":"product_tag-ursodeoxycholic-acid","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product\/61039","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/comments?post=61039"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media\/61040"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media?parent=61039"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_brand?post=61039"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat?post=61039"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_tag?post=61039"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}